PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

adapalene Side Effects

The reactions most often reported to the FDA for adapalene (also sold as Differin), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

178,147
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of adapalene come from 178,147 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 178,147 reports to the FDA Adverse Event Reporting System (FAERS) for adapalene (Differin): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

178,147

Reports Mentioning Death

32

0.0% of reports — not proof the medicine caused the death

Hospitalizations

358

0.2% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

DRY SKIN
44,990
SKIN BURNING SENSATION
41,633
ACNE
39,264
ERYTHEMA
38,379
SKIN IRRITATION
26,225
SKIN EXFOLIATION
21,251
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
16,186
RASH
15,520
OVERDOSE
13,210
PAIN OF SKIN
12,283
PRURITUS
11,826
HYPERSENSITIVITY
8,305
UNDERDOSE
4,949
CONDITION AGGRAVATED
4,946
RASH PAPULAR
4,147
RASH MACULAR
3,905
URTICARIA
3,298
SENSITIVE SKIN
2,791

Who Reports Side Effects

Gender Distribution

Female 122,669 (78%)
Male 34,451 (22%)
Unknown 75

Age Distribution

0-17 36,553 (42%)
18-44 43,798 (50%)
45-64 5,092 (6%)
65-74 970 (1%)
75+ 408 (0%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 32 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
DEATH 12
PAIN 5
DYSPNOEA 4
EMOTIONAL DISTRESS 4
WEIGHT DECREASED 4
ANXIETY 3
ASTHMA 3
BONE DENSITY DECREASED 3
COMPLETED SUICIDE 3
CONSTIPATION 3
DEPRESSION 3
HAEMATEMESIS 3
MALAISE 3
OSTEOPENIA 3
PLATELET COUNT DECREASED 3
RASH 3
AMYLASE DECREASED 2
ANAEMIA 2

Reactions in Hospitalization Reports

Top reactions in 358 reports where hospitalization was an outcome.

Reaction Reports
DYSPNOEA 41
PAIN 41
ANXIETY 39
HYPERSENSITIVITY 32
PULMONARY EMBOLISM 29
FATIGUE 27
DEPRESSION 26
NAUSEA 24
INJURY 23
DIZZINESS 22
EMOTIONAL DISTRESS 22
DEEP VEIN THROMBOSIS 21
HEADACHE 21
RASH 21
MALAISE 19
ABDOMINAL PAIN 18
ERYTHEMA 18
PYREXIA 18
DRY SKIN 17
PARAESTHESIA 17

Compare adapalene vs apremilast →

What the FAERS Data Reveals About adapalene Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 178,147 voluntary reports linked to adapalene and its brand equivalents (Differin), spanning 2004 through 2025. Of those, 32 (0.0%) listed death as an outcome and 358 (0.2%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 78% were female and 22% male; age distribution skews toward 18-44, with 43,798 reports in that bracket. The single most reported reaction is dry skin with 44,990 submissions, followed by skin burning sensation and acne.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.